Andrew Sinclair - 25 May 2023 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Director
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
25 May 2023
Net transactions value
$0
Form type
4
Filing time
26 May 2023, 18:30:56 UTC
Previous filing
14 Oct 2022
Next filing
02 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Stock option (right to buy) Award $0 +2,666 $0.000000 2,666 25 May 2023 Common Stock 2,666 $5.03 Direct F1
transaction SLNO Stock option (right to buy) Award $0 +10,000 $0.000000 10,000 26 May 2023 Common Stock 10,000 $5.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the Option shall vest on the earlier of the twelve-month anniversary of May 25, 2023 or the day before the next annual stockholder meeting, subject to the Reporting Person continuing to be a Service Provider through such date.
F2 The shares subject to the Option shall vest on November 26, 2023, subject to the Reporting Person continuing to be a Service Provider through such date.